Viatris, after closing massive West Virginia plant, sells it for $1news2022-04-01T15:18:33+00:00April 1st, 2022|Fierce Pharma|
Pfizer asks hourly staffers to return overpayments in aftermath of vendor’s cyberattack: reportsnews2022-04-01T14:59:29+00:00April 1st, 2022|Fierce Pharma|
Bristol Myers CEO Caforio takes pay cut as ‘human capital’ metric drags down bonusnews2022-04-01T14:26:26+00:00April 1st, 2022|Fierce Pharma|
Bristol Myers CEO Giovanni Caforio takes pay cut as ‘human capital’ metric drags down bonusnews2022-04-01T14:26:26+00:00April 1st, 2022|Fierce Pharma|
After pocketing $18.9M, Seagen’s Clay Siegall could reclaim spot among best-paid biopharma CEOsnews2022-04-01T13:19:25+00:00April 1st, 2022|Fierce Pharma|
Merck, amid pneumococcal vaccine race with Pfizer, suffers FDA delay for key pediatric usenews2022-04-01T13:13:30+00:00April 1st, 2022|Fierce Pharma|
Sanofi’s CDMO spinoff set for next month as new group targets 2022 revenues of €1Bnews2022-04-01T12:21:14+00:00April 1st, 2022|Fierce Pharma|
Fierce Pharma Asia—FDA oncology czar on China PD-1 rebuff; US Senate’s supply chain bill; Insilico’s AI targetsnews2022-04-01T11:37:22+00:00April 1st, 2022|Fierce Pharma|
Gilead zeros in with community groups around the world to help end AIDS epidemicnews2022-04-01T10:36:22+00:00April 1st, 2022|Fierce Pharma|
Novo Nordisk, trying to switch patients to Rybelsus, launches new TV adnews2022-04-01T07:52:49+00:00April 1st, 2022|Fierce Pharma|
